Clinical Trial Update: Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II clinical study evaluating SHR-8068 in combination with Adebrelimab for advanced renal cell carcinoma is currently recruiting. The trial also involve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Renal Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING